Meningococcal Sepsis in Patient with Paroxysmal Nocturnal Hemoglobinuria during Pegcetacoplan Therapy

Complement C5 inhibitors bring an increased risk for Neisseria infections. A novel complement C3 inhibitor, pegcetacoplan, was recently approved to treat paroxysmal nocturnal hemoglobinuria, a condition commonly treated with complement C5 inhibitors. We present a case of meningococcal sepsis in a p...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Leo Starck, Vuokko Nummi, Eira Poikonen, Anna-Elina Lehtinen, Pia Kivelä, Nathalie Friberg, Jukka Torvikoski, Maija Toropainen, Seppo Meri
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Centers for Disease Control and Prevention 2025-03-01
Sarja:	Emerging Infectious Diseases
Aiheet:	Meningococcal sepsis paroxysmal nocturnal hemoglobinuria pegcetacoplan Neisseria meningitidis complement
Linkit:	https://wwwnc.cdc.gov/eid/article/31/3/24-1182_article
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!